Status:
COMPLETED
Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders
Lead Sponsor:
Yuksek Ihtisas Hospital
Conditions:
Cardiomyopathy
Eligibility:
All Genders
21+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine clinical outcomes related to deactivation of Cardiac Resynchronization Therapy device in subjects with super response.
Eligibility Criteria
Inclusion
- super response to Cardiac Resynchronization Therapy
- near normal Left ventricular ejection fraction
- \>99% pacing
Exclusion
- \<99% pacing
- atrial fibrillation
- ischemic cardiomyopathy
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT02247427
Start Date
January 1 2009
End Date
June 1 2014
Last Update
September 25 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.